Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.5300
-0.0061 (-1.14%)
At close: Oct 27, 2026
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $1.79 million as of October 27, 2026. It is the 48,272nd most valuable company in the world and the 6,477th biggest in the United States. Its market cap has decreased by 92.06% in one year.
Market Cap
1.79M
Enterprise Value
-831.84K
1-Year Change
-92.06%
Global Rank
Country Rank
#6,477 United States
Category
ChartMarket Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $1.79M, a decrease of -94.63%. That is a compound annual growth rate of -74.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 1.79M | -87.86% |
| Dec 31, 2025 | 14.78M | -24.29% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 2.11M |
| BioRestorative Therapies | 2.01M |
| Revelation Biosciences | 2.01M |
| XORTX Therapeutics | 1.93M |
| Silo Pharma | 1.84M |
| Oragenics | 1.80M |
| GeoVax Labs | 1.77M |
| Matinas BioPharma Holdings | 1.63M |